Cephadex 250mg contains cephalexin (cefalexin), a first-generation cephalosporin antibiotic used to treat susceptible bacterial infections. Current Indian listings identify the 250mg product as a prescription oral medicine marketed by Cipla, with a 10-tablet pack listed for the tablet presentation. Cephalexin works by interfering with bacterial cell-wall formation, which can stop susceptible bacteria from surviving.
Cephadex should be used only when a bacterial infection is suspected or confirmed and when cephalexin is an appropriate antibiotic. It does not treat viral illnesses such as ordinary colds or influenza. Cipla's current product catalogue also lists Cephadex 125 DT, 250, 250 DT, 500, and a 125mg/5mL suspension; a current pharmacy listing additionally identifies a Cephadex 750mg tablet.
| Product Details | Information |
|---|---|
| Active Ingredient | Cephalexin (Cefalexin) |
| Indication | Susceptible bacterial infections |
| Manufacturer | Cipla Ltd — brand/marketer; exact manufacturing site not independently verified |
| Packaging | 10 tablets per strip |
| Strength | 250mg tablet; Cephadex range also documented in 125mg DT, 250mg capsule, 250mg DT, 500mg capsule, 125mg/5mL suspension and 750mg tablet presentations |
| Delivery Time | 10–13 days |

